S. Sivgin Et Al. , "Evaluation of the efficacy and safety of original filgrastim (Neupogen (R)), biosimilar filgrastim (Leucostim (R)) and Lenograstim (Granocyte (R)) in CD34(+) peripheral hematopoietic stem cell mobilization procedures for allogeneic hematopoietic stem cell transplant donors," TRANSFUSION AND APHERESIS SCIENCE , vol.54, no.3, pp.410-415, 2016
Sivgin, S. Et Al. 2016. Evaluation of the efficacy and safety of original filgrastim (Neupogen (R)), biosimilar filgrastim (Leucostim (R)) and Lenograstim (Granocyte (R)) in CD34(+) peripheral hematopoietic stem cell mobilization procedures for allogeneic hematopoietic stem cell transplant donors. TRANSFUSION AND APHERESIS SCIENCE , vol.54, no.3 , 410-415.
Sivgin, S., Karakuş, E., Keklik, M., ZARARSIZ, G., Solmaz, M., Kaynar, L., ... Eser, B.(2016). Evaluation of the efficacy and safety of original filgrastim (Neupogen (R)), biosimilar filgrastim (Leucostim (R)) and Lenograstim (Granocyte (R)) in CD34(+) peripheral hematopoietic stem cell mobilization procedures for allogeneic hematopoietic stem cell transplant donors. TRANSFUSION AND APHERESIS SCIENCE , vol.54, no.3, 410-415.
Sivgin, Serdar Et Al. "Evaluation of the efficacy and safety of original filgrastim (Neupogen (R)), biosimilar filgrastim (Leucostim (R)) and Lenograstim (Granocyte (R)) in CD34(+) peripheral hematopoietic stem cell mobilization procedures for allogeneic hematopoietic stem cell transplant donors," TRANSFUSION AND APHERESIS SCIENCE , vol.54, no.3, 410-415, 2016
Sivgin, Serdar Et Al. "Evaluation of the efficacy and safety of original filgrastim (Neupogen (R)), biosimilar filgrastim (Leucostim (R)) and Lenograstim (Granocyte (R)) in CD34(+) peripheral hematopoietic stem cell mobilization procedures for allogeneic hematopoietic stem cell transplant donors." TRANSFUSION AND APHERESIS SCIENCE , vol.54, no.3, pp.410-415, 2016
Sivgin, S. Et Al. (2016) . "Evaluation of the efficacy and safety of original filgrastim (Neupogen (R)), biosimilar filgrastim (Leucostim (R)) and Lenograstim (Granocyte (R)) in CD34(+) peripheral hematopoietic stem cell mobilization procedures for allogeneic hematopoietic stem cell transplant donors." TRANSFUSION AND APHERESIS SCIENCE , vol.54, no.3, pp.410-415.
@article{article, author={Serdar ŞIVGIN Et Al. }, title={Evaluation of the efficacy and safety of original filgrastim (Neupogen (R)), biosimilar filgrastim (Leucostim (R)) and Lenograstim (Granocyte (R)) in CD34(+) peripheral hematopoietic stem cell mobilization procedures for allogeneic hematopoietic stem cell transplant donors}, journal={TRANSFUSION AND APHERESIS SCIENCE}, year=2016, pages={410-415} }